trans1
-
Spine
TranS1® Announces NICE Guidance for Approval of AxiaLIF® in the UK’s National Health System (NHS)
WILMINGTON, N.C., Sept. 18, 2018 /PRNewswire/ — TranS1®, an innovator in spine technology development that pioneered the anterior retroperitoneal presacral approach utilizing the…
Read More » -
Spine
TranS1® Announces Three New Patents
Denver, Feb. 13, 2018 (GLOBE NEWSWIRE) — TranS1®, a spinal device company focused on breakthrough solutions that minimize tissue trauma,…
Read More » -
Spine
TranS1 announces AxiaLIF procedure could save hospitals US $3,500 per procedure
Wed May 11, 2016 TranS1 has announced that its axial lumbar interbody fusion (AxiaLIF) procedure has been shown to…
Read More » -
Financial
AxiaLIF could save $3.5k per spine surgery: 5 key notes
By Laura Dyrda TranS1’s AxiaLIF procedures could save the healthcare system thousands per procedure, according to a new economic analysis.…
Read More » -
Spine
TranS1 Announces New Vice President of Sales
DENVER–(BUSINESS WIRE)–TranS1®, a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine,…
Read More » -
Financial
Baxano Surgical, Inc. Reports Operating Results for the First Quarter of 2014, Issues Second Quarter 2014 Guidance
Baxano Surgical, Inc. Reports Operating Results for the First Quarter of 2014, Issues Second Quarter 2014 Guidance — First quarter…
Read More » -
Uncategorized
TranS1 Inc. Announces Closing of Acquisition of Baxano, Inc. and Financing Transaction; Changes Name to Baxano Surgical, Inc.
Trading under new ticker symbol “BAXS” to begin June 3, 2013 Completes financing of $17.2M at $2.28/share Two directors and…
Read More » -
Booming spinal surgery triggers innovative approaches
By Doug Smock Published: March 15th, 2013 The rapid growth of efforts to alleviate lower back pain is driving innovation…
Read More » -
Spine
TranS1 Inc. Reports Operating Results for the First Quarter of 2012, Issues Second Quarter 2012 Guidance
WILMINGTON, N.C., May 8, 2012 (GLOBE NEWSWIRE) — TranS1 Inc. TSON -5.60% , a medical device company focused on designing, developing and marketing…
Read More » -
Spine
TranS1 Offers Cutting-Edge Medical Devices and Training for the World’s Leading Spinal Surgeons in February’s Edition of Business Review USA
The human spine not only provides the structural support for the majority of our movements, but also houses some of…
Read More » -
Spine
TranS1 Inc. (TSON) Set Nearly A 6-Month High After AMA Approval
(RTTNews.com) – TranS1 Inc. (TSON) announced Monday morning that the American Medical Association Current Procedural Terminology Panel has voted to…
Read More » -
Spine
Category I Code Approved for TranS1’s AxiaLIF Pre-Sacral Interbody Fusion
WILMINGTON, N.C., Mar 5, 2012 (GlobeNewswire via COMTEX) — TranS1 Inc. TSON +29.24% , a medical device company focused on designing, developing and…
Read More » -
Spine
TranS1: Medicare Contractor Removes Noncoverage Policy For Procedure
TranS1 Inc. (TSON) said a Medicare administrative contractor removed its non-coverage policy for the medical-device company’s spine procedure AxiaLIF effective…
Read More » -
TranS1 Inc. Announces Closing of Public Offering of Common Stock
WILMINGTON, N.C., Sept. 26, 2011 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) today announced that it closed its previously announced public…
Read More » -
TranS1 Inc. Announces Pricing of Public Offering of Common Stock
WILMINGTON, N.C., Sept. 21, 2011 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) today announced that it has priced its public offering…
Read More »